A5103016590- Autoimmune Neurological Disorders and Treatments
- Genetics and Neurodevelopmental Disorders
- Neuroscience and Neuropharmacology Research
- Peripheral Neuropathies and Disorders
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS oral health manifestations
- Oral microbiology and periodontitis research
- Epilepsy research and treatment
- Mosquito-borne diseases and control
- Neurological Complications and Syndromes
- RNA regulation and disease
- Multiple Sclerosis Research Studies
- Viral Infections and Outbreaks Research
- Science, Research, and Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Ocular Diseases and Behçet’s Syndrome
- Sarcoidosis and Beryllium Toxicity Research
- Biotechnology and Related Fields
- Adenosine and Purinergic Signaling
- Amino Acid Enzymes and Metabolism
- Glioma Diagnosis and Treatment
- Malaria Research and Control
- Insect Pest Control Strategies
- Cytomegalovirus and herpesvirus research
Emory University
2022-2025
Children's Healthcare of Atlanta
2022-2024
University of Virginia Health System
2023
University of Colorado Denver
2023
Children's Hospital Colorado
2023
Rady Children's Hospital-San Diego
2023
University of Southern California
2023
Seattle Children's Hospital
2023
University of Washington
2023
New York University
2023
<h3>Objectives</h3> How brain MRI lesions associate with outcomes in pediatric anti-NMDA receptor encephalitis (pNMDARE) is unknown. In this study, we correlate T2-hyperintense clinical pNMDARE. <h3>Methods</h3> This was a multicenter retrospective cohort study from 11 institutions. Children younger than 18 years pNMDARE were included. One-year assessed by the modified Rankin Score (mRS) good (mRS ≤2) and poor ≥3) outcomes. <h3>Results</h3> A total of 175 subjects included, 1-year mRS...
To determine the differential diagnosis of leptomeningeal enhancement (LME) and compare rates LME by in children
To assess whether initial ancillary tests (brain magnetic resonance imaging-MRI, electroencephalogram-EEG, and/or cerebrospinal fluid-CSF white blood cell count) are abnormal in children with isolated psychiatric symptoms and anti-NMDA receptor encephalitis.
Background: Rates of sleep problems in children with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis are unknown. Methods: We used a retrospective observational cohort database diagnosis NMDA at single freestanding institution. One-year outcomes were assessed the pediatric modified Rankin Score (mRS), 0 to 2 as good and 3 or greater poor outcome. Results: Ninety-five percent (39/41) had dysfunction onset; 34% (11/32) reported 1 year. Sleep onset propofol use not associated Poor year...
<h3>Objective:</h3> To correlate MRI brain lesions with clinical outcomes in pediatric anti-NMDA receptor encephalitis (pNMDARE). <h3>Background:</h3> Up to 50% of MRIs NMDARE are reportedly abnormal. However, data is limited on range and types abnormalities, also how abnormal associate pNMDARE. <h3>Design/Methods:</h3> This was a multi-center retrospective cohort study ten institutions. defined as positive CSF NMDA-receptor antibody at least one neuropsychiatric symptom. Patients prior HSV...